AddLife AB (publ) (LON:0REZ)

Market Cap	1.54B
Revenue (ttm)	831.12M
Net Income (ttm)	31.11M
Shares Out	n/a
EPS (ttm)	0.26
PE Ratio	49.46
Forward PE	25.21
Dividend	0.06 (0.04%)
Ex-Dividend Date	May 9, 2025

Volume	253
Average Volume	6,808
Open	155.15
Previous Close	152.38
Day's Range	154.70 - 155.20
52-Week Range	130.50 - 207.60
Beta	1.89
RSI	23.45
Earnings Date	Feb 4, 2026

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment. It offers products and solutions, including instruments and equipment, plastic consumables, cell biology, reagents, general ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1906
• Employees: 2,181
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0REZ

Financial Performance

In 2024, AddLife AB's revenue was 10.29 billion, an increase of 6.21% compared to the previous year's 9.69 billion. Earnings were 252.00 million, an increase of 32.63%.

Financial numbers in SEK